Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
AstraZeneca's Imfinzi Perioperative Regimen Shows Improved Survival Outcomes In Bladder Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers AZN
Small-Cap OS Therapies Inks Commercial Manufacture Agreements For Lead Cancer Drug For Rare Type Of Bone Cancer
Via Benzinga
Exposures Product Safety
Tickers OSTX
ISO-CERT International Certification Office Expands Services for ISO, FDA, and CE Marking
Via Get News
Exposures Product Safety
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
GCDRI announces the provision of CE Marking and FDA certification services
Via AB Newswire
Exposures Product Safety
Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing
Via The Motley Fool
Exposures Product Safety
Tickers VRTX
Bob's Repair AC, Heating and Solar Experts Las Vegas Launches Workforce and Innovation Initiative to Tackle HVAC Changes
Via GetFeatured
Topics Product Recall
Exposures Legal Product Safety
APLT Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT Deadline in 5 Days: Kessler Topaz Meltzer &amp; Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Why Is Blood Cancer Focused Moleculin Biotech Stock Trading More Than 400% On Thursday?
Via Benzinga
Exposures Product Safety
Tickers MBRX
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
DEADLINE ALERT: Kaplan Fox Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Tech Entrepreneur Transforms Personal Struggle into Revolutionary AI Platform Called Magai
Via Press Release Distribution Service
Topics Artificial Intelligence Product Recall
Exposures Artificial Intelligence Legal Product Safety
BioMedNewsBreaks – RenovoRx Inc. (NASDAQ: RNXT) Announces $12.1M Underwritten Public Offering
Via Investor Brand Network
Exposures Product Safety
Tickers RNXT
SpringWorks Therapeutics Secures FDA Approval For Second Cancer Drug
Via Benzinga
Exposures Product Safety
Tickers SWTX
Reports Reveal New York Magazine, Prohibitionists Collaborated to Create Series Against MDMA Therapy
Via Investor Brand Network
Exposures Product Safety
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends
Via MarketBeat
Exposures Product Safety
Tickers HIMS LFVN LLY NVO
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Applied Therapeutics, Inc. (APLT) - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Trapped in addiction: Lebogang is finally free from one of South Africa’s dangerous drug
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Travere Therapeutics Sparks Retail Frenzy As Stock Hits Over 2-Year High On FDA Approval Plan For Kidney-Disease Drug
Via Stocktwits
Exposures Product Safety
Tickers IWM TVTX VTI XBI
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT SHAREHOLDER ALERT: Applied Therapeutics Investors are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Travere Therapeutics Skyrockets After Reaching FDA Deal For Kidney Disease Drug
Via Investor's Business Daily
Exposures Product Safety
Tickers TVTX
Nano Cap Lipella Pharmaceuticals Stock Jumps On Positive Trial Data In Patients With Sore Mouth Membranes
Via Benzinga
Exposures Product Safety
Tickers LIPO
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
Via Investor's Business Daily
Exposures Product Safety
Tickers BHVN
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI BBAI SOUN TALK
Avant Technologies and Ainnova Advance Toward FDA Clinical Trial with Selection of Top CRO
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AVAI
Biodexa Stock Surges On FDA's Fast-Track Tag For Treatment Of Cancer-Causing Condition: Retail Confidence Peaks
Via Stocktwits
Exposures Product Safety
Tickers BDRX
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.